Skip to main content

Table 3 Blood pressure control and use of antihypertensive medication among CKD patients with hypertension according to level of UACR

From: Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study

Characteristics Overall, n (%, 95% CIs) UACR, mg/mmol, n (%, 95% CIs)
<3.0 ≥ 3.0 ≥3.0 and diabetes
n = 267 N = 56 N = 211 N = 107
BP ≤ 140/90 mm Hg, n (%, 95% CI) 51 (19.1, 14.6 – 24.3) 13 (23.2, 13.0 – 36.4) 38 (18, 13.1 – 23.9) 20 (18.7, 11.8 – 27.4)
BP ≤ 130/80 mm Hg, n (%, 95% CI) 17 (6.4, 3.8 – 10.0) 6 (10.7, 4.0 – 21.9) 11 (5.2, 2.6 – 9.1) 6 (5.6, 2.1 – 11.8)
Use of antihypertensive medications, n (%, 95% CI) 130 (48.7, 42.6 – 54.9) 33 (58.9, 45.0 – 71.9) 97 (46, 39.1 – 52.9) 54 (50.5, 40.6 – 60.3)
  1. UACR = Urinary Albumin to Creatinine Ratio; BP = Blood Pressure.
  2. CKD (G3, A2 or worse) is defined as the eGFR < 60 mL/min/1.73 m2 estimated by CKD-EPIPK equation (0.686 × CKD-EPI1.059) or UACR ≥3 mg/mmol.
  3. Patients with diabetes mellitus and UACR ≥3 mg/mmol along with CKD and hypertension.